Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Shiffman

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Gastroenterology|October 27, 1999
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremiaM L Shiffman, C M Hofmann, M J Contos, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 1, 1993
Complications of transjugular intrahepatic portosystemic shunt: a comprehensive reviewA M Freedman, A J Sanyal, J Tisnado, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2008
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis TrialG T Everson, M L Shiffman, T R Morgan, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2008
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosisG T Everson, L Balart, S S Lee, et al.
The American Journal of Gastroenterology|December 22, 1999
Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantationR K Sterling, A J Sanyal, V A Luketic, et al.
Transplantation|January 12, 1999
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantationR A Fisher, J M Ham, A Marcos, et al.
Alimentary Pharmacology & Therapeutics|December 5, 2008
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trialG T Everson, M L Shiffman, J C Hoefs, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2004
A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitisR K Sterling, J J Salvatori, V A Luketic, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Gastroenterology|October 27, 1999
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremiaM L Shiffman, C M Hofmann, M J Contos, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 1, 1993
Complications of transjugular intrahepatic portosystemic shunt: a comprehensive reviewA M Freedman, A J Sanyal, J Tisnado, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2008
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis TrialG T Everson, M L Shiffman, T R Morgan, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2008
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosisG T Everson, L Balart, S S Lee, et al.
The American Journal of Gastroenterology|December 22, 1999
Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantationR K Sterling, A J Sanyal, V A Luketic, et al.
Transplantation|January 12, 1999
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantationR A Fisher, J M Ham, A Marcos, et al.
Alimentary Pharmacology & Therapeutics|December 5, 2008
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trialG T Everson, M L Shiffman, J C Hoefs, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2004
A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitisR K Sterling, J J Salvatori, V A Luketic, et al.
Pageof 10